SB2772 - 104th General Assembly

PSILOCYBIN ADVISORY BOARD
Last Action
5/15/2026 - House: Rule 19(a) / Re-referred to Rules Committee
Statutes Amended In Order of Appearance
New Act
Synopsis As Introduced
Creates the Illinois Psilocybin Advisory Board Act. Sets forth findings and defines terms. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Sets forth requirements for members of the Board. Provides that, within 3 months after the effective date of the Act, the Governor, the Senate President, the Speaker of the House, the Minority Leader of the House, and the Minority Leader of the Senate shall appoint certain individuals to the Board. Provides that, between January 1, 2027 and January 1, 2029, the Board shall meet at least once every 2 calendar months at a time and place determined by the chairperson or a majority of the voting members of the Board and that, after January 1, 2029, the Board shall meet at least once every calendar quarter. Provides that the Board shall perform certain duties, including publishing an annual report describing the Board's activities and making recommendations concerning (i) the safety and efficacy of psilocybin and other substances, (ii) potential requirements for providing psilocybin services to clients, (iii) a potential code of ethics and possible training requirements for facilitators, and (iv) public health considerations. Makes other changes. Effective immediately.

Senate Floor Amendment No. 3
Replaces everything after the enacting clause. Reinserts the provisions of the introduced bill, as amended by Senate Amendment No. 2, with the following changes. In a provision concerning the members of the Illinois Psilocybin Advisory Board, provides that if there is a vacancy for any reason, the applicable appointing authority shall appoint an individual to fill the vacancy in a timely manner (rather than appoint an individual to serve as a member in an acting capacity until the individual is approved by the Board as a member of the Board for the remainder of the unexpired term). Provides that the report the Board shall submit to the Governor and the General Assembly shall include an evaluation of (rather than a recommendation on) the medical efficacy of listed psychedelic substances based on medical, psychological, and scientific studies, research, clinical trials in the United States, and other information related to the safety and efficacy of each substance. Removes from the report the necessity to include recommendations concerning whether listed psychedelic substances may be included in an appropriate statutory or regulatory framework to avoid an unregulated de facto market for entheogenic substances other than psilocybin. Provides that the report shall include recommendations on the availability of Medicaid coverage for psilocybin (rather than entheogens) and associated services. Effective immediately.
Actions
Date Chamber Action
1/13/2026 Senate Filed with Secretary by Sen. Rachel Ventura
1/13/2026 Senate First Reading
1/13/2026 Senate Referred to Assignments
2/03/2026 Senate Assigned to Executive
2/09/2026 Senate Added as Co-Sponsor Sen. Mattie Hunter
2/11/2026 Senate Added as Co-Sponsor Sen. Emil Jones, III
2/19/2026 Senate Added as Co-Sponsor Sen. Mike Simmons
2/25/2026 Senate Added as Co-Sponsor Sen. Mark L. Walker
3/11/2026 Senate Do Pass Executive; 009-003-000
3/11/2026 Senate Placed on Calendar Order of 2nd Reading March 12, 2026
3/12/2026 Senate Second Reading
3/12/2026 Senate Placed on Calendar Order of 3rd Reading March 24, 2026
3/12/2026 Senate Added as Chief Co-Sponsor Sen. Mike Porfirio
3/26/2026 Senate Added as Co-Sponsor Sen. Karina Villa
3/27/2026 Senate Added as Chief Co-Sponsor Sen. Graciela Guzmán
4/10/2026 Senate Added as Co-Sponsor Sen. Michael E. Hastings
4/13/2026 Senate Senate Floor Amendment No. 1 Filed with Secretary by Sen. Rachel Ventura
4/13/2026 Senate Senate Floor Amendment No. 1 Referred to Assignments
4/14/2026 Senate Senate Floor Amendment No. 1 Assignments Refers to Executive
4/14/2026 Senate Senate Floor Amendment No. 2 Filed with Secretary by Sen. Rachel Ventura
4/14/2026 Senate Senate Floor Amendment No. 2 Referred to Assignments
4/15/2026 Senate Senate Floor Amendment No. 2 Assignments Refers to Executive
4/15/2026 Senate Senate Floor Amendment No. 2 Recommend Do Adopt Executive; 009-004-000
4/17/2026 Senate Rule 2-10 Third Reading Deadline Established As May 8, 2026
4/21/2026 Senate Senate Floor Amendment No. 3 Filed with Secretary by Sen. Rachel Ventura
4/21/2026 Senate Senate Floor Amendment No. 3 Referred to Assignments
4/28/2026 Senate Senate Floor Amendment No. 3 Assignments Refers to Executive
4/30/2026 Senate Senate Floor Amendment No. 3 Recommend Do Adopt Executive; 009-004-000
5/07/2026 Senate Added as Chief Co-Sponsor Sen. Willie Preston
5/07/2026 Senate Added as Co-Sponsor Sen. Celina Villanueva
5/07/2026 Senate Added as Co-Sponsor Sen. David Koehler
5/07/2026 Senate Added as Co-Sponsor Sen. Christopher Belt
5/07/2026 Senate Recalled to Second Reading
5/07/2026 Senate Senate Floor Amendment No. 2 Tabled Ventura
5/07/2026 Senate Senate Floor Amendment No. 3 Adopted; Ventura
5/07/2026 Senate Placed on Calendar Order of 3rd Reading
5/07/2026 Senate Third Reading - Passed; 041-013-000
5/07/2026 Senate Senate Floor Amendment No. 1 Tabled Pursuant to Rule 5-4(a)
5/08/2026 House Arrived in House
5/08/2026 House Chief House Sponsor Rep. Theresa Mah
5/08/2026 House Added Alternate Chief Co-Sponsor Rep. La Shawn K. Ford
5/12/2026 House First Reading
5/12/2026 House Referred to Rules Committee
5/12/2026 House Assigned to Executive Committee
5/12/2026 House Committee Deadline Extended-Rule 9(b) May 15, 2026
5/12/2026 House Motion Filed to Suspend Rule 21 Executive Committee; Rep. Robyn Gabel
5/12/2026 House Motion to Suspend Rule 21 - Prevailed 075-036-001
5/15/2026 House Rule 19(a) / Re-referred to Rules Committee